ENTRY       D01192                      Drug
NAME        Olopatadine hydrochloride (JP18/USP);
            Allelock (TN);
            Patanol (TN);
            Opatanol (TN)
PRODUCT
  GENERIC   OLOPATADINE (A-S Medication Solutions)
            OLOPATADINE (Akorn)
            OLOPATADINE (Akorn)
            OLOPATADINE HYDROCHLORIDE (A-S Medication Solutions)
            OLOPATADINE HYDROCHLORIDE (Akorn)
            OLOPATADINE HYDROCHLORIDE (Alembic Pharmaceuticals)
            OLOPATADINE HYDROCHLORIDE (Amneal Pharmaceuticals LLC)
            OLOPATADINE HYDROCHLORIDE (Apotex Corp.)
            OLOPATADINE HYDROCHLORIDE (Asclemed USA)
            OLOPATADINE HYDROCHLORIDE (Bryant Ranch Prepack)
            OLOPATADINE HYDROCHLORIDE (Bryant Ranch Prepack)
            OLOPATADINE HYDROCHLORIDE (Padagis Israel Pharmaceuticals)
            OLOPATADINE HYDROCHLORIDE (Proficient Rx LP)
            OLOPATADINE HYDROCHLORIDE (RPK Pharmaceuticals)
            OLOPATADINE HYDROCHLORIDE (Rising Pharmaceuticals)
            OLOPATADINE HYDROCHLORIDE (Sandoz)
            OLOPATADINE HYDROCHLORIDE (Somerset Therapeutics)
FORMULA     C21H23NO3. HCl
EXACT_MASS  373.1445
MOL_WEIGHT  373.8732
CLASS       Anti-allergic agent
             DG01557  Histamine receptor antagonist
              DG01482  Histamine receptor H1 antagonist
            Dermatological agent
             DG03243  Atopic dermatitis agent
REMARK      Therapeutic category: 1319 4490
            ATC code: R01AC08 S01GX09
            Chemical structure group: DG01039
            Product (DG01039): D01192<JP/US>
            Product (mixture): D12501<US>
EFFICACY    Antiallergic, H1 receptor antagonist
  DISEASE   Seasonal allergic rhinitis [DS:H01360]
COMMENT     Loratadine derivative
TARGET      HRH1 [HSA:3269] [KO:K04149]
  PATHWAY   hsa04020(3269)  Calcium signaling pathway
            hsa04080(3269)  Neuroactive ligand-receptor interaction
INTERACTION  
STR_MAP     map07212  Histamine H1 receptor antagonists
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             R RESPIRATORY SYSTEM
              R01 NASAL PREPARATIONS
               R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE
                R01AC Antiallergic agents, excl. corticosteroids
                 R01AC08 Olopatadine
                  D01192  Olopatadine hydrochloride (JP18/USP) &lt;JP/US&gt;
             S SENSORY ORGANS
              S01 OPHTHALMOLOGICALS
               S01G DECONGESTANTS AND ANTIALLERGICS
                S01GX Other antiallergics
                 S01GX09 Olopatadine
                  D01192  Olopatadine hydrochloride (JP18/USP) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Ophthalmic Agents
              Ophthalmic Anti-Allergy Agents
               Antihistamine
                Olopatadine
                 D01192  Olopatadine hydrochloride (JP18/USP)
             Respiratory Tract/Pulmonary Agents
              Antihistamines
               Histamine (H1) Receptor Antagonists, Mildly/Non-sedating
                Olopatadine
                 D01192  Olopatadine hydrochloride (JP18/USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              13  Agents affecting sensory organs
               131  Ophthalmic agents
                1319  Others
                 D01192  Olopatadine hydrochloride (JP18/USP)
             4  Agents affecting cellular function
              44  Allergic agents
               449  Miscellaneous
                4490  Miscellaneous
                 D01192  Olopatadine hydrochloride (JP18/USP)
            Drug groups [BR:br08330]
             Anti-allergic agent
              DG01557  Histamine receptor antagonist
               DG01482  Histamine receptor H1 antagonist
                DG01039  Olopatadine
                 D01192  Olopatadine hydrochloride
             Dermatological agent
              DG03243  Atopic dermatitis agent
               D01192  Olopatadine hydrochloride
            Drug classes [BR:br08332]
             Anti-allergic agent
              DG01482  Histamine receptor H1 antagonist
               D01192  Olopatadine hydrochloride
             Dermatological agent
              DG03243  Atopic dermatitis agent
               D01192  Olopatadine hydrochloride
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Histamine
                HRH1
                 D01192  Olopatadine hydrochloride (JP18/USP) &lt;JP/US&gt;
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D01192  Olopatadine hydrochloride
              D01192  Olopatadine hydrochloride tablets
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D01192
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D01192
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D01192
            Rx-to-OTC switch list in the USA [br08315.html]
             D01192
            Drug groups [BR:br08330]
             Anti-allergic agent
              DG01557  Histamine receptor antagonist
               DG01482  Histamine receptor H1 antagonist
                DG01039  Olopatadine
DBLINKS     CAS: 140462-76-6
            PubChem: 7848255
            ChEBI: 31933
            LigandBox: D01192
            NIKKAJI: J508.357E
ATOM        26
            1   X   Cl   25.5488  -17.6013
            2   O2x O    18.4771  -20.2698
            3   C8y C    17.6355  -19.1476
            4   C8y C    17.9161  -17.7450
            5   C2y C    19.1785  -17.1839
            6   C1x C    19.8798  -20.2698
            7   C8y C    20.4409  -17.8151
            8   C8y C    20.7214  -19.2178
            9   C8x C    16.9341  -16.7630
            10  C8y C    15.6016  -17.1839
            11  C8x C    15.2509  -18.5165
            12  C8x C    16.2328  -19.4983
            13  C8x C    22.1241  -19.6385
            14  C8x C    23.1060  -18.6567
            15  C8x C    22.8254  -17.3241
            16  C8x C    21.4929  -16.9034
            17  C2b C    19.1785  -15.7812
            18  C1b C    14.5495  -16.2021
            19  C6a C    13.2170  -16.6228
            20  O6a O    12.2351  -15.6410
            21  O6a O    12.8664  -17.9554
            22  C1b C    17.9865  -15.0638
            23  C1b C    17.9865  -13.6646
            24  N1c N    16.7747  -12.9650
            25  C1a C    15.5841  -13.6522
            26  C1a C    16.7746  -11.5441
BOND        27
            1     4   5 1
            2     2   6 1
            3     5   7 1
            4     3   4 1
            5     6   8 1
            6     2   3 1
            7     7   8 1
            8     4   9 2
            9     9  10 1
            10   10  11 2
            11   11  12 1
            12    3  12 2
            13    8  13 2
            14   13  14 1
            15   14  15 2
            16   15  16 1
            17    7  16 2
            18    5  17 2
            19   10  18 1
            20   18  19 1
            21   19  20 1
            22   19  21 2
            23   17  22 1
            24   22  23 1
            25   23  24 1
            26   24  25 1
            27   24  26 1
///
